methyl 2-{[(2-fluorophenyl)sulfonyl]amino}-5,6,7,8-tetrahydro-1-naphthalenecarboxylate | 681246-78-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: methyl 2-{[(2-fluorophenyl)sulfonyl]amino}-5,6,7,8-tetrahydro-1-naphthalenecarboxylate
• 英文别名: methyl 2-[(2-fluorophenyl)sulfonylamino]-5,6,7,8-tetrahydronaphthalene-1-carboxylate
• CAS: 681246-78-6
• 化学式: C₁₈H₁₈FNO₄S
• 分子量: 363.41
• InChiKey: ARVLRXZXPLOANE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  25
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  80.8
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  methyl 2-{[(2-fluorophenyl)sulfonyl]amino}-5,6,7,8-tetrahydro-1-naphthalenecarboxylate 在 sodium hydride 、 吡啶 、 sodium iodide 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 72.42h， 以57.1%的产率得到2-[({2-[3-(diethylamino)propoxy]phenyl}sulfonyl)amino]-5,6,7,8-tetrahydro-1-naphthalenecarboxylic acid
  参考文献：
  名称：

  Sulfonamides having antiangiogenic and anticancer activity

  摘要：

  描述了具有蛋氨酸氨基肽酶-2抑制剂（MetAP2）的化合物。还描述了包括这些化合物的药物组合物、使用这些化合物的治疗方法、抑制血管生成的方法以及治疗癌症的方法。

  公开号：

  US20040167128A1
• 作为产物：
  描述：

  2-羟基-1-萘酸甲酯 在 palladium on activated charcoal 吡啶 、 盐酸 、 palladium diacetate 、 氢气 、 caesium carbonate 、 4,5-双二苯基膦-9,9-二甲基氧杂蒽 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 吡啶 、 甲醇 、 二氯甲烷 、 水 为溶剂， -20.0~100.0 ℃ 、10.34 MPa 条件下， 反应 7.5h， 生成 methyl 2-{[(2-fluorophenyl)sulfonyl]amino}-5,6,7,8-tetrahydro-1-naphthalenecarboxylate
  参考文献：
  名称：

  Discovery and Optimization of Anthranilic Acid Sulfonamides as Inhibitors of Methionine Aminopeptidase-2:  A Structural Basis for the Reduction of Albumin Binding

  摘要：

  Methionine aminopeptidase-2 (MetAP2) is a novel target for cancer therapy. As part of an effort to discover orally active reversible inhibitors of MetAP2, a series of anthranilic acid sulfonamides with micromolar affinities for human MetAP2 were identified using affinity selection by mass spectrometry (ASMS) screening. These micromolar hits were rapidly improved to nanomolar leads on the basis of insights from protein crystallography; however, the compounds displayed extensive binding to human serum albumin and had limited activity in cellular assays. Modifications based on structural information on the binding of lead compounds to both MetAP2 and domain III of albumin allowed the identification of compounds with significant improvements in both parameters, which showed good cellular activity in both proliferation and methionine processing assays.

  DOI：

  10.1021/jm0601001

文献信息

• [EN] SULFONAMIDES HAVING ANTIANGIOGENIC AND ANTICANCER ACTIVITY<br/>[FR] SULFONAMIDES AYANT UNE ACTIVITE ANTI-ANGIOGENIQUE ET ANTICANCEREUSE
  申请人：ABBOTT LAB

  公开号：WO2004033419A1

  公开（公告）日：2004-04-22

  Compounds having methionine aminopeptidase-2 inhibitory (MetAP2) are described. Also described are pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, methods of inhibiting angiogenesis, and methods of treating cancer.

  描述了具有甲硫氨酸氨肽酶-2（MetAP2）抑制剂的化合物。还描述了包含这些化合物的制药组合物，使用这些化合物进行治疗的方法，抑制血管生成的方法以及治疗癌症的方法。
• SULFONAMIDES HAVING ANTIANGIOGENIC AND ANTICANCER ACTIVITY
  申请人：Abbott Laboratories

  公开号：EP1549613A1

  公开（公告）日：2005-07-06
• US7491718B2
  申请人：——

  公开号：US7491718B2

  公开（公告）日：2009-02-17
• Sulfonamides having antiangiogenic and anticancer activity
  申请人：——

  公开号：US20040157836A1

  公开（公告）日：2004-08-12

  Compounds having methionine aminopeptidase-2 inhibitory (MetAP2) are described. Also described are pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, methods of inhibiting angiogenesis, and methods of treating cancer.

  描述了具有蛋氨酸氨基肽酶-2抑制剂（MetAP2）的化合物。还描述了包括这些化合物的药物组合物、使用这些化合物的治疗方法、抑制血管生成的方法以及治疗癌症的方法。
• Discovery and Optimization of Anthranilic Acid Sulfonamides as Inhibitors of Methionine Aminopeptidase-2:  A Structural Basis for the Reduction of Albumin Binding
  作者：George S. Sheppard、Jieyi Wang、Megumi Kawai、Steve D. Fidanze、Nwe Y. BaMaung、Scott A. Erickson、David M. Barnes、Jason S. Tedrow、Lawrence Kolaczkowski、Anil Vasudevan、David C. Park、Gary T. Wang、William J. Sanders、Robert A. Mantei、Fabio Palazzo、Lora Tucker-Garcia、Pingping Lou、Qian Zhang、Chang H. Park、Ki H. Kim、Andrew Petros、Edward Olejniczak、David Nettesheim、Phillip Hajduk、Jack Henkin、Richard Lesniewski、Steven K. Davidsen、Randy L. Bell

  DOI：10.1021/jm0601001

  日期：2006.6.1

  Methionine aminopeptidase-2 (MetAP2) is a novel target for cancer therapy. As part of an effort to discover orally active reversible inhibitors of MetAP2, a series of anthranilic acid sulfonamides with micromolar affinities for human MetAP2 were identified using affinity selection by mass spectrometry (ASMS) screening. These micromolar hits were rapidly improved to nanomolar leads on the basis of insights from protein crystallography; however, the compounds displayed extensive binding to human serum albumin and had limited activity in cellular assays. Modifications based on structural information on the binding of lead compounds to both MetAP2 and domain III of albumin allowed the identification of compounds with significant improvements in both parameters, which showed good cellular activity in both proliferation and methionine processing assays.